Summary
- Current Price
- As of today, TARS price is $84.41, down -3.23% in the most recent trading session on
- Current Price All-Time High
- TARS price is currently -7.78% below its historical high of $91.53 set on
- Market Cap
- TARS current market cap is $4B, up +55.33% over the past 365 days
- Revenue
- TARS current annual revenue is $451.36M, up +146.71% year-over-year
- Next Earnings
- The next earnings release for TARS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Tarsus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: TARS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tarsusrx.com |
| Employees | 323 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $84.41 | |
| Price, 1D Change | -3.23% | |
| $4B | ||
| - | ||
| - | ||
| 0.58 | ||
| $451.36M | ||
| Revenue, 1Y Change | +146.71% | |
| -$1.59 | ||
| EPS, 1Y Change | +48.27% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.59 | ||
| EPS Estimate | -$2.13 | N/A |
| EPS Est. Change | -34.12% | N/A |
| $451.36M | ||
| Revenue Estimate | $713.62M | N/A |
| Revenue Est. Change | +58.10% | N/A |
| Current Price | $84.41 | |
| Price Target | $94.00 | - |
| Price Tgt. Change | +11.37% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.27 | -$3.07 | +6.06% | |
| -$1.40 | -$1.59 | -13.64% | |
| -$2.13 | N/A | -34.12% | |
| $2.33 | N/A | +246.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $175.47M | $182.95M | +4.26% | |
| $444.18M | $451.36M | +1.62% | |
| $713.62M | N/A | +58.10% | |
| $925.34M | N/A | +105.01% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $84.41 | |
| $68.79 | ||
| $66.45 | ||
| $65.39 | ||
| $69.40 | ||
| $5.38 | ||
| 0.58 | ||
| $3.66 | ||
| 74.58 | ||
| 78.43% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $451.36M | ||
| -$1.59 | ||
| $420.68M | ||
| 93.20% | ||
| -$70.97M | ||
| -15.72% | ||
| -$66.42M | ||
| -14.72% | ||
| -$69.15M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.24 | ||
| 3.85 | ||
| 3.82 | ||
| - | ||
| 3 | ||
| 10.09 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 6.11 | ||
| 10.68 | ||
| -72.27 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $343.43M | ||
| $417.83M | ||
| $566.90M | ||
| $522.78M | ||
| $223.47M | ||
| $135.70M | ||
| $83.04M | ||
| $0.00 | ||
| $16.39M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $517.78M | ||
| $491.65M | ||
| $30.68M | ||
| $0.00 | ||
| $1.82M | ||
| $0.00 | ||
| $2.06M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$12.45M | ||
| -$42.12M | ||
| $143.39M | ||
| $9.86M | ||
| -$22.31M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Oppenheimer | → | |
| Mizuho | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| Guggenheim | → | |
| Barclays | ||
| Mizuho | ||
| Guggenheim | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TARS
FAQ
- What is the ticker symbol for Tarsus Pharmaceuticals, Inc.?
- The ticker symbol for Tarsus Pharmaceuticals, Inc. is NASDAQ:TARS
- Does Tarsus Pharmaceuticals, Inc. pay dividends?
- No, Tarsus Pharmaceuticals, Inc. does not pay dividends
- What sector is Tarsus Pharmaceuticals, Inc. in?
- Tarsus Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Tarsus Pharmaceuticals, Inc. in?
- Tarsus Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Tarsus Pharmaceuticals, Inc. based in?
- Tarsus Pharmaceuticals, Inc. is headquartered in United States
- When did Tarsus Pharmaceuticals, Inc. go public?
- Tarsus Pharmaceuticals, Inc. initial public offering (IPO) was on October 16, 2020
- Is Tarsus Pharmaceuticals, Inc. in the S&P 500?
- No, Tarsus Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Tarsus Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Tarsus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Tarsus Pharmaceuticals, Inc. in the Dow Jones?
- No, Tarsus Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Tarsus Pharmaceuticals, Inc. last earnings report?
- Tarsus Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2026
- When does Tarsus Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Tarsus Pharmaceuticals, Inc. is November 4, 2026
Data Sources & References
- TARS Official Website www.tarsusrx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1819790/000181979026000019/0001819790-26-000019-index.htm
- TARS Profile on Yahoo Finance finance.yahoo.com/quote/TARS
- TARS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tars